C22ORF34-BRD1 Fusion FISH Probe
The C22ORF34-BRD1 Fusion FISH Probe is used to confirm a fusion of the C22ORF34 and BRD1 genes. The fusion of the C22ORF34 and BRD1 genes has been associated with Acute Myeloid Leukemia. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| C22ORF34-BRD1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| C22ORF34-BRD1-20-AQAQ | 20 (40 μL) | 200 μL |
|
BRD1 Gene Summary
This gene encodes a bromodomain-containing protein that localizes to the nucleus and can interact with DNA and histone tails. The encoded protein is a component of the MOZ/MORF acetyltransferase complex and can stimulate acetylation of histones H3 and H4, thereby potentially playing a role in gene activation. Variation in this gene is associated with schizophrenia and bipolar disorder in some study populations. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]
Gene Name: Bromodomain Containing 1
Chromosome: CHR22: 50166936 -50218452
Locus: 22q13.33
C22orf34 Gene Summary
The Chromosome 22 Open Reading Frame 34 (C22orf34) gene is located on chr22 :50013289-50051190 at 22q13.33.
Gene Name: Chromosome 22 Open Reading Frame 34
Chromosome: CHR22: 50013289 -50051190
Locus: 22q13.33
Gene Diseases
The C22ORF34 BRD1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Acute Myeloid Leukemia |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|